PDL BioPharma, Inc. SEC Filings http://investor.pdl.com/ PDL BioPharma, Inc. SEC Filings en 8-K: Report of unscheduled material events or corporate event http://investor.pdl.com/sec-filings/sec-filing/8-k/0000882104-19-000056 PDL BIOPHARMA, INC. Tue, 21 May 2019 06:02:53 -0400 PDL BioPharma, Inc. SEC Filings 18536 10-Q: Quarterly report which provides a continuing view of a company's financial position http://investor.pdl.com/sec-filings/sec-filing/10-q/0000882104-19-000054 PDL BIOPHARMA, INC. Thu, 09 May 2019 16:15:01 -0400 PDL BioPharma, Inc. SEC Filings 18511 8-K: Report of unscheduled material events or corporate event http://investor.pdl.com/sec-filings/sec-filing/8-k/0000882104-19-000053 PDL BIOPHARMA, INC. Thu, 09 May 2019 16:07:00 -0400 PDL BioPharma, Inc. SEC Filings 18506 DEFA14A: Additional proxy soliciting materials - definitive http://investor.pdl.com/sec-filings/sec-filing/defa14a/0000882104-19-000048 PDL BIOPHARMA, INC. Mon, 06 May 2019 06:12:28 -0400 PDL BioPharma, Inc. SEC Filings 18481 DEFA14A: Additional proxy soliciting materials - definitive http://investor.pdl.com/sec-filings/sec-filing/defa14a/0000882104-19-000046 PDL BIOPHARMA, INC. Tue, 30 Apr 2019 17:34:35 -0400 PDL BioPharma, Inc. SEC Filings 18471 DEF 14A: Official notification to shareholders of matters to be brought to a vote ("Proxy") http://investor.pdl.com/sec-filings/sec-filing/def-14a/0000882104-19-000044 PDL BIOPHARMA, INC. Tue, 30 Apr 2019 17:26:37 -0400 PDL BioPharma, Inc. SEC Filings 18466 SC 13D: Filing by person(s) reporting owned shares of common stock in a public company >5% http://investor.pdl.com/sec-filings/sec-filing/sc-13d/0001193125-19-110809 PDL BIOPHARMA, INC. Thu, 18 Apr 2019 15:36:41 -0400 PDL BioPharma, Inc. SEC Filings 18456 3: Initial filing by director officer or owner of more than ten percent. http://investor.pdl.com/sec-filings/sec-filing/3/0000899243-19-010887 PDL BIOPHARMA, INC. Thu, 18 Apr 2019 15:32:41 -0400 PDL BioPharma, Inc. SEC Filings 18451 4/A: Amendment to a previously filed 4 http://investor.pdl.com/sec-filings/sec-filing/4a/0000882104-19-000041 PDL BIOPHARMA, INC. Tue, 16 Apr 2019 17:22:17 -0400 PDL BioPharma, Inc. SEC Filings 18436 4/A: Amendment to a previously filed 4 http://investor.pdl.com/sec-filings/sec-filing/4a/0000882104-19-000039 PDL BIOPHARMA, INC. Tue, 16 Apr 2019 17:22:15 -0400 PDL BioPharma, Inc. SEC Filings 18431